Raltegravir 800mg twice daily appears a good alternative to efavirenz for HIV-TB treatment
Taking isoniazid preventive therapy for one year reduces the risk of TB in people taking antiretroviral therapy
Determine LAM urine antigen TB test is highly cost-effective for use in hospitalised people living with HIV
HIV infection does not compromise multidrug-resistant TB treatment outcomes in Botswana
Preventing malaria and diarrhoea delays need for antiretroviral therapy
Novel TB combination regimen shows potent activity in randomised short-term clinical trial
Co-administration of rifampicin and efavirenz does not reduce efavirenz concentrations or efficacy
Changing epidemiology of opportunistic infections in US: still common in inner cities
